ARTV Artiva Biotherapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 6, 2026
$6,83
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$2,71rendah 52m
$14,53tinggi 52m
Kapitalisasi Pasar (MRQ)
$333M
P/E
-1.3
EPS
$-3.43
Pendapatan
$0
lencana Anda
Rentang 52M
$3–$15
Peringkat Analis
BUY
Target Harga
$36
P/E
-1.3
ROE
·
Margin Laba Bersih
·
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
ARTV Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$6.83
Kapitalisasi Pasar (MRQ)
$333M
P/E
-1.3
EPS
$-3.43
Pendapatan
$0
Rentang 52M
$3–$15
ARTV Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan$02023-12-31 → 2025-12-31
EPS$-3.432023-12-31 → 2025-12-31
Arus Kas Bebas·2024-12-31 → 2024-12-31
Margin bersih·2024-12-31 → 2024-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | ARTV | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E | -1.3 | · | · | · | |
| P/B (MRQ) | 1.0 | · | 2.2 | Kurang nilai | |
| Harga / FCF (TTM) | -4.3 | · | · | · | |
| Harga / Arus Kas (TTM) | -4.4 | · | · | · | |
| Price / Tangible Book (Harga / Nilai Buku Berwujud) | 0.9 | · | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | ARTV | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 24.2 | · | 5.3 | Likuiditas kuat |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
| Metrik | Tren 5 Tahun | ARTV | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Revenue YoY (Pendapatan YoY) | -99.2% | · | · | · |
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
| Metrik | Tren 5 Tahun | ARTV | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.) | ≈$0.00 | · | · | · |
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
-1.7%
Laporan Berikutnya
Nov 10, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 27, 2026 | $-0.63 | $-0.64 | 1.2% |
| 31 Maret 2026 | Mei 7, 2026 | $-0.95 | $-0.89 | -6.8% |
| 31 Des. 2025 | $-0.85 | $-0.84 | -0.84% | |
| 30 Sep. 2025 | $-0.88 | $-0.89 | 0.83% | |
| 30 Juni 2025 | $-0.87 | $-0.82 | -5.7% | |
| 31 Maret 2025 | $-0.83 | $-0.72 | -14.5% | |
| 31 Des. 2024 | $-0.66 | $-0.77 | 14.3% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $0 | $251.0K | $33M | |
| R&D Expense | $70M | $50M | $50M | |
| SG&A Expense | $20M | $17M | $14M | |
| Operating Expenses | $90M | $68M | $64M | |
| Operating Income | $-90M | $-67M | $-31M | |
| Other Non-op | $-14.0K | $157.0K | $195.0K | |
| Pretax Income | · | $-65M | $-29M | |
| Income Tax | $0 | $0 | $72.0K | |
| Net Income | $-84M | $-65M | $-29M | |
| EPS (Basic) | $-3.43 | $-5.81 | $-35.78 | |
| EPS (Diluted) | $-3.43 | $-5.81 | $-35.78 | |
| Shares (Basic) | 24,444,057 | 11,258,851 | 802,747 | |
| Shares (Diluted) | 24,444,057 | 11,258,851 | 802,747 | |
| EBITDA | · | $-65M | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $27M | $40M | $54M | |
| Short-term Investments | $81M | $145M | $23M | |
| Receivables | · | $0 | $1M | |
| Prepaid Expense | $5M | $3M | $1M | |
| Current Assets | $113M | $189M | $80M | |
| PP&E (Net) | $7M | $6M | $8M | |
| PP&E (Gross) | $15M | $12M | $12M | |
| Accum. Depreciation | $8M | $6M | $4M | |
| Other Non-current Assets | $458.0K | $267.0K | $392.0K | |
| Total Assets | $131M | $210M | $105M | |
| Accounts Payable | $355.0K | $1M | $614.0K | |
| Accrued Liabilities | $10M | $7M | $8M | |
| Current Liabilities | $13M | $12M | $12M | |
| Capital Leases | $8M | $11M | $13M | |
| Other Non-current Liabilities | · | $73.0K | $73.0K | |
| Total Liabilities | $21M | $23M | $51M | |
| Common Stock | $3.0K | $3.0K | · | |
| Retained Earnings | $-331M | $-247M | $-181M | |
| AOCI | $103.0K | $-129.0K | $308.0K | |
| Stockholders' Equity | $110M | $187M | $-162M | |
| Liabilities + Equity | $131M | $210M | $105M | |
| Shares Outstanding | 24,595,550 | 24,291,607 | 809,758 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $3M | $2M | $2M | |
| Stock-based Comp | $7M | $7M | $7M | |
| Other Non-cash | · | $930.0K | · | |
| Operating Cash Flow | $-77M | $-55M | $-47M | |
| CapEx | $3M | $642.0K | $3M | |
| Investing Cash Flow | $63M | $-120M | $-26M | |
| Stock Issued | $0 | $167M | · | |
| Net Stock Activity | · | $167M | · | |
| Financing Cash Flow | $9.0K | $162M | $24M | |
| Net Change in Cash | $-13M | $-13M | $-49M | |
| Free Cash Flow | · | $-56M | · |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | · | -26805.6% | · | |
| Net Margin | · | -26045.0% | · | |
| Pretax Margin | · | -26045.0% | · | |
| EBITDA Margin | · | -25837.0% | · | |
| ROA | · | -41.5% | · | |
| ROE | · | -33.7% | · | |
| ROIC | · | -36.0% | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | · | 15.4 | · | |
| Quick Ratio | · | 15.1 | · |
Efisiensi
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | · | 0.0 | · | |
| Receivables Turnover | · | 0.5 | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Book Value / Share | · | $7.68 | · | |
| Revenue / Share | · | $0.02 | · | |
| Cash Flow / Share | · | $-4.89 | · | |
| Cash / Share | · | $1.66 | · | |
| EPS (TTM) | $-3.43 | $-5.81 | · |
Tingkat Pertumbuhan
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | · | -99.2% | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $0 | $251.0K | · | |
| Net Income TTM | $-84M | $-65M | · | |
| Market Cap | · | $245M | · | |
| P/E | -1.3 | -1.7 | · | |
| P/S | · | 975.5 | · | |
| P/B | · | 1.3 | · | |
| P / Tangible Book | 0.9 | 1.3 | · | |
| P / Cash Flow | · | -4.4 | · | |
| P / FCF | · | -4.4 | · | |
| Earnings Yield | -80.0% | -57.6% | · |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $0 | $0 | $0 | $251.0K | $2M | $27M | $3M | |
| R&D Expense | $22M | $19M | $17M | $18M | $18M | $17M | $13M | $14M | $12M | $11M | $11M | $13M | $11M | |
| SG&A Expense | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $3M | $3M | $4M | |
| Operating Expenses | $27M | $24M | $22M | $23M | $23M | $22M | $18M | $18M | $16M | $15M | $14M | $16M | $15M | |
| Operating Income | $-27M | $-24M | $-22M | $-23M | $-23M | $-22M | $-18M | $-18M | $-16M | $-14M | $-12M | $11M | $-12M | |
| Other Non-op | $-1.0K | $2.0K | $-2.0K | $-3.0K | $-5.0K | $-4.0K | $-7.0K | $-6.0K | $23.0K | $147.0K | $168.0K | $50.0K | $31.0K | |
| Net Income | $-25M | $-24M | $-21M | $-22M | $-21M | $-20M | $-16M | $-17M | $-18M | $-14M | $-12M | $11M | $-11M | |
| EPS (Basic) | $-0.63 | $-0.95 | $-0.85 | $-0.88 | $-0.87 | $-0.83 | $34.35 | $-0.92 | $-22.00 | $-17.24 | $-14.89 | $13.98 | $-14.09 | |
| EPS (Diluted) | $-0.63 | $-0.95 | $-0.85 | $-0.88 | $-0.87 | $-0.83 | $34.35 | $-0.92 | $-22.00 | $-17.24 | $-14.89 | $1.62 | $-14.09 | |
| Shares (Basic) | 39,413,236 | 24,678,420 | · | 24,481,722 | 24,378,823 | 24,341,978 | · | 18,896,829 | 811,210 | 809,758 | · | 806,714 | 800,889 | |
| Shares (Diluted) | 39,413,236 | 24,678,420 | · | 24,481,722 | 24,378,823 | 24,341,978 | · | 18,896,829 | 811,210 | 809,758 | · | 6,967,099 | 800,889 | |
| EBITDA | $-27M | $-24M | · | $-23M | $-23M | $-22M | · | $-18M | $-16M | · | · | · | · |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $301M | $21M | $27M | $26M | $28M | $30M | $40M | $56M | $34M | · | $54M | · | · | |
| Short-term Investments | $48M | $66M | $81M | $97M | $114M | $136M | $145M | $91M | $12M | · | $23M | · | · | |
| Receivables | · | · | · | · | · | · | · | $569.0K | $569.0K | · | $1M | · | · | |
| Prepaid Expense | $3M | $2M | $5M | $6M | $7M | $4M | $3M | $3M | $2M | · | $1M | · | · | |
| Current Assets | $352M | $89M | $113M | $130M | $149M | $170M | $189M | $151M | $50M | · | $80M | · | · | |
| PP&E (Net) | $6M | $6M | $7M | $7M | $7M | $7M | $6M | $7M | $7M | · | $8M | · | · | |
| PP&E (Gross) | $15M | $15M | $15M | $15M | $14M | $14M | $12M | $12M | $12M | · | $12M | · | · | |
| Accum. Depreciation | $10M | $9M | $8M | $8M | $7M | $7M | $6M | $5M | $5M | · | $4M | · | · | |
| Other Non-current Assets | $809.0K | $458.0K | $458.0K | $418.0K | $38.0K | $13.0K | $267.0K | $298.0K | $330.0K | · | $392.0K | · | · | |
| Total Assets | $369M | $106M | $131M | $149M | $169M | $191M | $210M | $226M | $76M | · | $105M | · | · | |
| Accounts Payable | $1M | $2M | $355.0K | $848.0K | $1M | $2M | $1M | $1M | $823.0K | · | $614.0K | · | · | |
| Accrued Liabilities | $10M | $6M | $10M | $7M | $6M | $6M | $7M | $8M | $6M | · | $8M | · | · | |
| Current Liabilities | $15M | $11M | $13M | $11M | $11M | $12M | $12M | $13M | $11M | · | $12M | · | · | |
| Capital Leases | $7M | $7M | $8M | $9M | $10M | $10M | $11M | $11M | $12M | · | $13M | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | $73.0K | $73.0K | $74.0K | · | $73.0K | · | · | |
| Total Liabilities | $21M | $18M | $21M | $20M | $20M | $22M | $23M | $25M | $51M | · | $51M | · | · | |
| Common Stock | $5.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | · | · | · | · | · | |
| Retained Earnings | $-379M | $-354M | $-331M | $-310M | $-288M | $-267M | $-247M | $-231M | $-213M | · | $-181M | · | · | |
| AOCI | $-21.0K | $-18.0K | $103.0K | $87.0K | $2.0K | · | $-129.0K | $338.0K | $121.0K | · | $308.0K | · | · | |
| Stockholders' Equity | $348M | $88M | $110M | $129M | $149M | $169M | $187M | $201M | $-191M | · | $-162M | · | · | |
| Liabilities + Equity | $369M | $106M | $131M | $149M | $169M | $191M | $210M | $226M | $76M | · | $105M | · | · | |
| Shares Outstanding | 48,792,279 | 24,716,672 | 24,291,607 | 24,544,904 | 24,393,524 | 24,363,119 | 24,291,607 | 24,287,144 | 814,202 | · | 809,758 | · | · |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $692.0K | $666.0K | $666.0K | $662.0K | $641.0K | $628.0K | $614.0K | $627.0K | $603.0K | $587.0K | $594.0K | $556.0K | · | |
| Stock-based Comp | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | · | |
| Other Non-cash | · | $307.0K | · | · | · | $-2M | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-20M | $-21M | $-15M | $-19M | $-23M | $-20M | $-15M | $-12M | $-14M | $-15M | $-11M | $-11M | · | |
| CapEx | $415.0K | $242.0K | $421.0K | $600.0K | $1M | $511.0K | $64.0K | $96.0K | $464.0K | $18.0K | $636.0K | $179.0K | · | |
| Investing Cash Flow | $18M | $15M | $16M | $16M | $21M | $10M | $-966.0K | $-131M | $1M | $10M | $-3M | $-493.0K | · | |
| Stock Issued | · | · | · | · | · | · | $0 | · | · | · | · | · | · | |
| Financing Cash Flow | $283M | $-112.0K | $-121.0K | $-37.0K | $-72.0K | $239.0K | $-30.0K | $164M | · | · | $962.0K | $23M | · | |
| Net Change in Cash | $280M | $-6M | $1M | $-3M | $-2M | $-10M | $-16M | $22M | $-14M | $-5M | $-12M | $12M | · | |
| Free Cash Flow | · | $-21M | · | · | · | $-20M | · | · | · | · | · | · | · |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -9.3% | -15.8% | · | -11.5% | -17.3% | -21.2% | · | -15.5% | -47.0% | · | · | · | · | |
| ROE | -10.1% | -18.3% | · | -13.0% | 101.1% | -24.1% | · | -17.4% | 18.7% | · | · | · | · |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 24.2 | 8.2 | · | 11.6 | 13.8 | 13.9 | · | 11.3 | 4.6 | · | · | · | · | |
| Quick Ratio | 24.0 | 8.0 | · | 11.1 | 13.2 | 13.6 | · | 11.1 | 4.4 | · | · | · | · |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.12 | $3.55 | · | $5.26 | $6.11 | $6.93 | · | $8.28 | $-234.70 | · | · | · | · | |
| Cash Flow / Share | · | $-0.85 | · | · | · | $-0.82 | · | · | · | · | · | · | · | |
| Cash / Share | $6.18 | $0.85 | · | $1.04 | $1.17 | $1.25 | · | $2.30 | $42.06 | · | · | · | · | |
| EPS (TTM) | $-3.31 | $-3.55 | · | $31.77 | $31.73 | $10.60 | · | $-55.05 | $-52.51 | $-44.60 | · | · | · |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $251.0K | $251.0K | · | $251.0K | $251.0K | $251.0K | · | $3M | $29M | $33M | · | · | · | |
| Net Income TTM | $-91M | $-87M | · | $-79M | $-75M | $-72M | · | $-61M | $-33M | $-26M | · | · | · | |
| Market Cap | $473M | $159M | · | $70M | $37M | $73M | · | $375M | · | · | · | · | · | |
| P/E | -2.9 | -1.8 | · | 0.1 | 0.0 | 0.3 | · | -0.3 | · | · | · | · | · | |
| P/S | 1885.6 | 634.2 | · | 280.7 | 146.7 | 291.2 | · | 144.3 | · | · | · | · | · | |
| P/B | 1.4 | 1.8 | · | 0.5 | 0.2 | 0.4 | · | 1.9 | · | · | · | · | · | |
| P / Tangible Book | 1.4 | 1.8 | · | 0.5 | 0.2 | 0.4 | · | 1.9 | · | · | · | · | · | |
| P / Cash Flow | · | -7.6 | · | · | · | -3.7 | · | · | · | · | · | · | · | |
| Earnings Yield | -34.1% | -55.1% | · | 1107.0% | 2101.3% | 353.3% | · | -356.3% | · | · | · | · | · |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Pendapatan | $0 | $251.0K | $33M |
| Margin Operasi % | · | -26805.6% | · |
| Laba Bersih | $-84M | $-65M | $-29M |
| EPS Dilusian | $-3.43 | $-5.81 | $-35.78 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Rasio Lancar | · | 15.4 | · |
| Rasio Cepat | · | 15.1 | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Arus Kas Bebas | · | $-56M | · |
Pemilik institusional (13F) 73 pengaju · $392.5M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
73
Nilai yang dipegang
$392.5M
Posisi baru
39
Posisi yang keluar
7
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 39 (+27 vs Kuartal sebelumnya) | 7 (+2 vs Kuartal sebelumnya) | 25 (+22 vs Kuartal sebelumnya) | 2 (-10 vs Kuartal sebelumnya) | +23.5M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $174.169.727 | 17.955.642 | 44,38% | Saham |
| VIKING GLOBAL INVESTORS LP | $25.260.410 | 2.604.166 | 6,44% | Saham |
| Blackstone Inc. | $23.313.339 | 2.403.437 | 5,94% | Saham |
| 5AM Venture Management, LLC | $22.827.049 | 2.353.304 | 5,82% | Saham |
| Venrock Adviser, LLC | $19.822.881 | 2.043.596 | 5,05% | Saham |
| FRANKLIN RESOURCES INC | $19.373.063 | 1.997.223 | 4,94% | Saham |
| Caligan Partners LP | $16.840.277 | 1.736.111 | 4,29% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $9.523.606 | 981.815 | 2,43% | Saham |
| SAMSARA BIOCAPITAL, LLC | $9.262.152 | 954.861 | 2,36% | Saham |
| Blue Owl Capital Holdings LP | $8.483.057 | 874.542 | 2,16% | Saham |
| Propel Bio Management, LLC | $6.755.429 | 696.436 | 1,72% | Saham |
| BlackRock, Inc. | $6.738.842 | 694.726 | 1,72% | Saham |
| CITADEL ADVISORS LLC | $5.910.947 | 609.376 | 1,51% | Saham |
| SILVERARC CAPITAL MANAGEMENT, LLC | $5.092.500 | 525.000 | 1,30% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $3.433.947 | 353.845 | 0,87% | Saham |
| BOOTHBAY FUND MANAGEMENT, LLC | $3.049.438 | 314.375 | 0,78% | Saham |
| Nantahala Capital Management, LLC | $2.910.000 | 300.000 | 0,74% | Saham |
| Revelation Capital Management, LLC | $2.903.317 | 299.311 | 0,74% | Saham |
| Alyeska Investment Group, L.P. | $2.654.066 | 273.615 | 0,68% | Saham |
| ACUTA CAPITAL PARTNERS, LLC | $2.526.035 | 260.416 | 0,64% | Saham |
| KVP Capital Advisors, LP | $1.940.000 | 200.000 | 0,49% | Saham |
| WELLINGTON MANAGEMENT GROUP LLP | $1.882.848 | 194.108 | 0,48% | Saham |
| UBS Group AG | $1.784.994 | 184.020 | 0,45% | Saham |
| SEVEN GRAND MANAGERS, LLC | $1.697.500 | 175.000 | 0,43% | Saham |
| STATE STREET CORP | $1.607.911 | 165.764 | 0,41% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $1.464.700 | 151.000 | 0,37% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $1.439.412 | 148.393 | 0,37% | Saham |
| ADAR1 Capital Management, LLC | $1.150.653 | 118.624 | 0,29% | Saham |
| VANGUARD GROUP INC | $1.055.366 | 246.006 | 0,27% | Saham |
| Simplify Asset Management Inc. | $983.144 | 101.355 | 0,25% | Saham |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $824.500 | 85.000 | 0,21% | Saham |
| TWO SIGMA INVESTMENTS, LP | $762.178 | 78.575 | 0,19% | Saham |
| NORTHERN TRUST CORP | $741.303 | 76.423 | 0,19% | Saham |
| DAFNA Capital Management LLC | $650.880 | 67.101 | 0,17% | Saham |
| Quadrature Capital Ltd | $478.647 | 49.345 | 0,12% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $434.705 | 44.815 | 0,11% | Saham |
| XTX Topco Ltd | $412.337 | 42.509 | 0,11% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $301.796 | 31.113 | 0,08% | Saham |
| Velan Capital Investment Management LP | $242.500 | 25.000 | 0,06% | Saham |
| Atom Investors LP | $221.684 | 22.854 | 0,06% | Saham |
| BAILARD, INC. | $200.790 | 20.700 | 0,05% | Saham |
| Spark Investment Management LLC | $160.050 | 16.500 | 0,04% | Saham |
| GOLDMAN SACHS GROUP INC | $153.066 | 15.780 | 0,04% | Saham |
| Squarepoint Ops LLC | $144.094 | 14.855 | 0,04% | Saham |
| ALLIANCEBERNSTEIN L.P. | $135.606 | 13.980 | 0,03% | Saham |
| Vanguard Global Advisers, LLC | $116.187 | 11.978 | 0,03% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $115.391 | 11.896 | 0,03% | Saham |
| NEW YORK STATE COMMON RETIREMENT FUND | $59.170 | 6.100 | 0,02% | Saham |
| Russell Investments Group, Ltd. | $56.852 | 5.861 | 0,01% | Saham |
| WELLS FARGO & COMPANY/MN | $53.156 | 5.480 | 0,01% | Saham |
Aktivis & pemilik 5%+ 3 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×5 pengajuan | 23 Juli 2026 | 37,90% | Amandemen | · | SEC |
| GC Corp, GC Cell Corporation, Yong-Jun Huh | 28 Mei 2026 | 12,30% | Amandemen | · | SEC |
| GC Corp., GC Cell Corporation, Yong-Jun Huh | 29 Juli 2024 | · | Pengajuan awal | Investasi pasif | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 17 orang dalam · 9 pejabat · 8 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Fred Aslan | Chief Executive Officer | 15 Sep. 2026 A | 1.604.765 | 0 | 6 | $-1.384.500 |
| Thad Allen Huston | Chief Financial Officer | 10 Maret 2026 A | 220.000 | 0 | 0 | $0 |
| Neha Krishnamohan | Chief Financial Officer | 15 Nov. 2025 F | 99.356 | 0 | 0 | $0 |
| Gines Diego Miralles | President & Head of R&D | 9 Sep. 2026 A | 122.500 | 0 | 0 | $0 |
| Jennifer Bush | COO, CLO, Compliance Officer | 9 Sep. 2026 A | 374.529 | 0 | 2 | $-172.842 |
| Subhashis Banerjee | Chief Medical Officer | 9 Sep. 2026 A | 170.947 | 0 | 4 | $-179.573 |
| Christopher Horan | Chief Tech Operations Officer | 9 Sep. 2026 A | 323.084 | 0 | 2 | $-178.773 |
| Heather Raymon | SVP, Research and Development | 19 Mei 2026 S | 148.228 | 0 | 1 | $-27.886 |
| Thorsten Graef | Chief Medical Officer | 26 Feb. 2025 A | 80.000 | 0 | 0 | $0 |
| Daniel G. Baker | Direktur | 10 Sep. 2026 A | · | 0 | 0 | $0 |
| Laura Stoppel | Direktur | 10 Sep. 2026 A | · | 0 | 0 | $0 |
| Elaine K. Sorg | Direktur | 10 Sep. 2026 A | · | 0 | 0 | $0 |
| Alison Moore | Direktur | 10 Sep. 2026 A | · | 0 | 0 | $0 |
| Brian Daniels | Direktur | 10 Sep. 2026 A | · | 0 | 0 | $0 |
| HOUGEN ELIZABETH L | Direktur | 10 Sep. 2026 A | · | 0 | 0 | $0 |
| Yong-Jun Huh | Direktur | 22 Juli 2024 C | 1.260.512 | 0 | 0 | $0 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | Pemilik 10% | 22 Juli 2024 C | 194.108 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 12 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| IWC · iShares Trust | 0,01% | 15.680 SH | 11 Sep. 2026 | Harian |
| IWM · iShares Trust | 0,00% | 138.068 SH | 11 Sep. 2026 | Harian |
| RSSL · Global X Funds | 0,00% | 2.230 NS | 31 Juli 2026 | N-PORT |
| IWO · iShares Trust | 0,00% | 13.050 SH | 11 Sep. 2026 | Harian |
| DCOR · Dimensional ETF Trust | 0,00% | 3.029 NS | 31 Juli 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 5.863 NS | 31 Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 269.149 SH | 19 Agu 2026 | Harian |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 699.899 SH | 19 Agu 2026 | Harian |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 26.837 SH | 19 Agu 2026 | Harian |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2.934 SH | 19 Agu 2026 | Harian |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1.342 SH | 19 Agu 2026 | Harian |
| IWN · iShares Trust | · | 35.940 SH | 11 Sep. 2026 | Harian |
ARTV Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 12 analis
BELI
Target median
$40.00
+485,7%
4 33,3%
Beli Kuat
7 58,3%
Beli
1 8,3%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
5 analis · 2026-09-29Target rata-rata $35.80 +424,2%
← Di bawah semua target
Harga saat ini $6.83
Rendah$23.00
Rata-rata$35.80
Tinggi$41.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| ARTV | · | -1.3 | -99.2% | · | · | · |
| FENC | $263M | -22.6 | -6.1% | -21.8% | -69.6% | · |
| CYPH | $97M | 16.6 | · | · | 6.1% | · |
| SRZN | · | · | · | · | · | · |
| ZNTL | $93M | -0.7 | · | · | -49.5% | · |
| OCGN | $422M | -5.6 | 8.8% | -1537.4% | 1488.8% | · |
| BNTC | $460M | -13.7 | · | · | -25.0% | · |
| INDP | $6M | -0.1 | · | · | -2820.8% | · |
| SCTX | · | · | · | · | · | · |
| EBS | $644M | 13.3 | -28.8% | 7.1% | 9.9% | · |
| BBOT | $1.00B | -2.9 | · | · | -146.2% | · |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 6, 2026